Intel (Nasdaq: INTC) announced the receipt of 510(k) market clearance from the U.S. Food and Drug Administration (FDA) on Intel’s ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE